CASQ2 and catecholaminergic polymorphic ventricular tachycardia: Studies of cellular and molecular pathogenesis of CPVT have unravelled adaptive processes that adjust and cope with the presence of a mutant CASQ2 protein and/or with the substantial lack of CASQ2 (Song et al. 2007; Valle et al. 2014).